Curatis Holding AG (0QNS)
LSE
Closed
Sep 25, 2026
Day's Range
19.2052 wk Range
11.55Overview - 0QNS - Curatis Holding AG
Key Statistics
Valuation
Enterprise Value
101.85M
Price / Book
‪2.22‬
EV / EBITDA
‪-87.65‬
Profitability
Profit Margin
‪-13.11%‬
Operating Margin
‪-4.55%‬
Return on Assets
‪-1.73%‬
Return on Equity
‪-3.08%‬
Ownership
Float
1.13M
Held by Insiders
‪77.91%‬
Held by Institutions
‪0.75%‬
Price stats
Beta
‪-0.80‬
Peers - 0QNS - Curatis Holding AG
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
- 0QNSLSECuratis Holding AG+27.14%52-week change—P/E (Trailing)‪-13.11%‬Profit Margin
- 0MTDLSESwedish Orphan Biovitrum AB+36.33%52-week change45.80P/E (Trailing)‪15.54%‬Profit Margin
- 0LERLSETeva Pharmaceutical Industries Ltd. ADR+52.30%52-week change31.31P/E (Trailing)‪51.78%‬Profit Margin
- 0A5VLSEViatris Inc.+32.46%52-week change11.39P/E (Trailing)‪11.88%‬Profit Margin
- 0DOLLSEBiofrontera AG+27.22%52-week change0.04P/E (Trailing)‪-17.92%‬Profit Margin
- 0AAJLSEPolyPeptide Group AG+41.70%52-week change0.30P/E (Trailing)‪3.14%‬Profit Margin
- 0SANLSESandoz Group AG+29.63%52-week change—P/E (Trailing)‪5.53%‬Profit Margin
Profile Summary - 0QNS - Curatis Holding AG
About
Curatis Holding AG is a Swiss-based specialty pharmaceutical company dedicated to the acquisition, development, and commercialization of innovative medicines for rare and specialty care diseases. Operating primarily in two business areas, it holds exclusive distribution rights for over 40 products in Switzerland,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
